Preliminary concept development

Build the concept.
Validate the route.

CosTinia helps pet-care brands turn an intended format, market, and use direction into a documented private-label development brief.

Brief alignmentFormulation targetsClaims review
Unbranded sample containers and formulation materials arranged on a development worktable
Product-development contextConceptual visualization · Not a final product or facility
Follow the development pathway
01
02 / 06Discover and align

Begin with the brief
the market actually needs.

The first conversation aligns the intended species context, use direction, format, target market, packaging question, timeline, and evidence expectations.

Your context
Market, audience, format, positioning, timeline, and project constraints
Concept fit
BT87 cream, BT57 ointment, Pet Mist, or a custom direction
First decision
A development brief with open assumptions stated clearly
03 / 06Active format and formulation targets

Turn direction into
working assumptions.

The formulation stage defines the intended active format, matrix, physical profile, use direction, and the questions the next development work must resolve.

  1. 01
    Active-format selection

    Confirm identity and naming before that language reaches public product copy.

  2. 02
    Formulation targets

    Set texture, pH direction where relevant, application, and packaging needs.

  3. 03
    Document assumptions

    Separate provisional categories from a final ingredient and label declaration.

Prepared sample vessels arranged beside generic analytical equipment
Formulation-planning contextConceptual visualization · Not study data or a CosTinia laboratory
04 / 06Validation and review planning

Design the route
before promising the result.

Compatibility, stability, safety, species suitability, claims, and regional review are planned against the intended final concept. Planning is not presented as completed validation.

Compatibility
Matrix-specificDefine how the intended material and finished formulation will be assessed together.
Stability
Method-ledAgree conditions, measures, timing, and acceptance criteria.
Claims
Evidence-awareKeep proposed benefits qualified until the supporting work is approved.
Regional review
Market-specificAlign use, species, safety, label, and documentation with the launch region.
Development status / 04
Every displayed product remains a preliminary private-label concept.
Review the technical pathway
05 / 06Packaging and commercial planning

Keep the pack
inside the evidence boundary.

Packaging, pilot planning, and commercial preparation follow the concept's documented format and development status.

  1. 01
    Format selection

    Choose the cream, ointment, or mist direction that fits the project brief.

  2. 02
    BT57 packaging

    Jars or tubes are potential formats for the ointment concept.

  3. 03
    Pet Mist packaging

    100 ml, 250 ml, 500 ml, or custom spray-bottle concepts may be considered.

  4. 04
    Label direction

    Keep concept status and open specifications visible until final review.

  5. 05
    Pilot planning

    Define quantities, timing, and evaluation needs after formula scope is agreed.

  6. 06
    Commercial planning

    Discuss supply and launch needs as project requirements, not guaranteed standard terms.

06 / 06Documented handoff

Leave each stage
with the next decision clear.

Project outputs are scoped during the conversation. Commercial structures remain discussion options rather than implied standard offerings.

  1. 01
    Development brief

    Target market, format, species context, scope, and assumptions.

  2. 02
    Validation plan

    Open questions, proposed methods, review owners, and decision points.

  3. 03
    Reviewed handoff

    Version-controlled technical context appropriate to the agreed development stage.